CHAIR
:
SPEAKER
(S):
Doris Taylor, PhD, Director, Ctr for Cardiovascular Repair, University of Minnesota
C. Randall Mills, PhD, President & CEO, Osiris Therapeutics, Inc
David Scadden, MD, Co-Director, Harvard Stem Cell Institute
Description
This panel will discuss intellectual property and business issues related to cells and cell-based therapeutics, with particular focus on stem cells. Speakers bring perspective from within the industry, as well as from advisory and advocacy positions.
Objectives:
Understand how research and clinical experience with stem cells in cardiovascular repair is a model for stem therapeutics in general.
Discuss global perspectives on stem cell research and therapeutics and the United States' competitive position in the global environment.
Learn about the next wave of commercial applications for stem cells, and the related patent issues; how to best position your business in these new markets.